Accueil › Cancer de l'ovaire › Maryland › Baltimore
Essais cliniques pour Cancer de l'ovaire à Baltimore, MD
22 études pour Cancer de l'ovaire recherchent des participants dans et autour de Baltimore (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Recrutement en coursPhase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 2
- Johns Hopkins University, Baltimore
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Recrutement en coursPhase 3
- Research Site, Baltimore
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Recrutement en coursPhase 2
- University of Maryland, Baltimore /ID# 275308, Baltimore
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Recrutement en coursPhase 3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital Of Baltimore, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Recrutement en coursPhase 1
- United Theranostics, Glen Burnie · à 9 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Recrutement en coursPhase 2
- Greater Baltimore Medical Center, Baltimore
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Recrutement en coursPhase 1/2
- Research Site, Baltimore
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Recrutement en coursPhase 3
- Greater Baltimore Medical Center, Towson · à 8 mi
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Recrutement en coursPhase 2/3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recrutement en coursPhase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Recrutement en coursPhase 2
- The John Hopkins Hospital, Baltimore
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Recrutement en coursPhase 3
- University of Maryland, Baltimore
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Recrutement en coursPhase 3
- Greater Baltimore Medical Center, Towson · à 8 mi
EXoPERT EMERALD Clinical Study
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- John Hopkins University, Baltimore
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Recrutement en coursPhase 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Recrutement en coursPhase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recrutement en coursPhase 2
- SCRI - Maryland Oncology Hematology, P.A., Annapolis · à 22 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · à 8 mi
Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
Recrutement en coursPhase 2
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Recrutement en coursÉtude observationnelle
- Johns Hopkins University School of Medicine, Baltimore
- Anne Arundel Health System, Annapolis · à 22 mi
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Recrutement en coursPhase 1/2
- Johns Hopkins, Baltimore
Essais pour Cancer de l'ovaire dans d'autres villes
- Houston, TX89 études
- New York City, NY69 études
- Boston, MA61 études
- Los Angeles, CA50 études
- Nashville, TN49 études
- Arlington, VA46 études
- Philadelphia, PA44 études
- Columbus, OH39 études
- St. Louis, MO38 études
- Chicago, IL36 études
- San Antonio, TX31 études
- Cleveland, OH30 études
Autres études à Baltimore
- Cancer du poumon non à petites cellules60 études
- Cancer du sein47 études
- Cancer de la prostate43 études
- Cancer du poumon40 études
- Cancer (tous types)37 études
- Cancer colorectal31 études
- Cancer du pancréas31 études
- Cancer métastatique28 études
- Obésité25 études
- Insuffisance cardiaque24 études
- Cancer de la vessie24 études
- Accident vasculaire cérébral22 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.